MoneyWorks4Me

Astrazeneca Pharma I - Quaterly Results

30 May 2023 Evaluate
The revenue for the March 2023 quarter is pegged at Rs. 2847.03 millions, about 22.74% up against Rs. 2319.63 millions recorded during the year-ago period.The Net Profit of the company slipped to Rs. 172.71 millions from Rs. 279.84 millions, a decline of -38.28% on QoQ basis.The company reported a good operating profit of 678.46 millions compared to 416.45 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 2847.03 2319.63 22.74 10029.71 8056.00 24.50 10029.71 8056.00 24.50
Other Income 79.97 36.84 117.07 261.02 147.58 76.87 261.02 147.58 76.87
PBIDT 678.46 416.45 62.92 1914.27 1009.33 89.66 1914.27 1009.33 89.66
Interest 0.88 2.07 -57.49 8.33 9.47 -12.04 8.33 9.47 -12.04
PBDT 275.29 414.38 -33.57 1503.65 999.86 50.39 1503.65 999.86 50.39
Depreciation 42.49 44.07 -3.59 162.60 169.49 -4.07 162.60 169.49 -4.07
PBT 232.80 370.31 -37.13 1341.05 830.37 61.50 1341.05 830.37 61.50
TAX 60.09 90.47 -33.58 348.12 214.43 62.35 348.12 214.43 62.35
Deferred Tax -23.73 -1.67 1320.96 -34.90 -11.86 194.27 -34.90 -11.86 194.27
PAT 172.71 279.84 -38.28 992.93 615.94 61.21 992.93 615.94 61.21
Equity 50.00 50.00 0.00 50.00 50.00 0.00 50.00 50.00 0.00
PBIDTM(%) 23.83 17.95 32.74 19.09 12.53 52.34 19.09 12.53 52.34
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..